TWIST BIOSCIENCE CORPTWST
ASignal's systematic analysis rates TWST as Neutral.
Reflects the latest available analysis · analyzed Oct 28, 2026
The case on TWST
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong revenue growth (23.2% YoY)
- High gross margin (51.96%) indicating pricing power
- Solid financial health with low debt-to-equity (0.24x)
- Current price near upper Bollinger Band, suggesting momentum
- Cash-rich balance sheet with $166.84M cash vs $108.59M debt
- Negative free cash flow (-$64.82M)
- Negative profit and operating margins
- Negative return on equity (-29.59%)
- MACD below signal line with negative histogram
- No Reddit mentions, indicating low retail interest or potential visibility risk
- Forward P/E of -399.62x indicates unprofitability and speculative valuation
See the full verdict on TWST
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes TWST
Most investors never get a second opinion, let alone several. ASignal runs TWST past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.